Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 58

Related Citations for PubMed (Select 18692859)


Transcriptional profiles in CD8+ T cells from HIV+ progressors on HAART are characterized by coordinated up-regulation of oxidative phosphorylation enzymes and interferon responses.

Wu JQ, Dwyer DE, Dyer WB, Yang YH, Wang B, Saksena NK.

Virology. 2008 Oct 10;380(1):124-35. doi: 10.1016/j.virol.2008.06.039. Epub 2008 Aug 9.


Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.

López M, Soriano V, Rallón N, Cascajero A, González-Lahoz J, Benito JM.

Eur J Immunol. 2008 Jun;38(6):1548-58. doi: 10.1002/eji.200738054.


Genome-wide analysis of primary CD4+ and CD8+ T cell transcriptomes shows evidence for a network of enriched pathways associated with HIV disease.

Wu JQ, Dwyer DE, Dyer WB, Yang YH, Wang B, Saksena NK.

Retrovirology. 2011 Mar 16;8:18. doi: 10.1186/1742-4690-8-18.


Human immunodeficiency virus interactions with CD8+ T lymphocytes.

Saksena NK, Wu JQ, Potter SJ, Wilkinson J, Wang B.

Curr HIV Res. 2008 Jan;6(1):1-9. Review.


No major differences in the functional profile of HIV Gag and Nef-specific CD8+ responses between long-term nonprogressors and typical progressors.

López M, Soriano V, Lozano S, Ballesteros C, Cascajero A, Rodés B, De La Vega E, González-Lahoz J, Benito JM.

AIDS Res Hum Retroviruses. 2008 Sep;24(9):1185-95. doi: 10.1089/aid.2008.0006.


CD8+ cell anti-HIV activity rapidly increases upon discontinuation of early antiretroviral therapy.

Killian MS, Roop J, Ng S, Hecht FM, Levy JA.

J Clin Immunol. 2009 May;29(3):311-8. doi: 10.1007/s10875-009-9275-y. Epub 2009 Feb 3.


Impaired response of HIV type 1-specific CD8(+) cells from antiretroviral-treated patients.

Lozano JM, De la Rosa O, García-Jurado G, Luque J, Solana R, Kindelán JM, Rivero A, Peña J.

AIDS Res Hum Retroviruses. 2007 Oct;23(10):1279-82.


Comparisons of CD8+ T cells specific for human immunodeficiency virus, hepatitis C virus, and cytomegalovirus reveal differences in frequency, immunodominance, phenotype, and interleukin-2 responsiveness.

Jagannathan P, Osborne CM, Royce C, Manion MM, Tilton JC, Li L, Fischer S, Hallahan CW, Metcalf JA, McLaughlin M, Pipeling M, McDyer JF, Manley TJ, Meier JL, Altman JD, Hertel L, Davey RT Jr, Connors M, Migueles SA.

J Virol. 2009 Mar;83(6):2728-42. doi: 10.1128/JVI.02128-08. Epub 2009 Jan 7.


Identification of a particular HIV-specific CD8+ T-cell subset with a CD27+ CD45RO-/RA+ phenotype and memory characteristics after initiation of HAART during acute primary HIV infection.

Lécuroux C, Girault I, Urrutia A, Doisne JM, Deveau C, Goujard C, Meyer L, Sinet M, Venet A.

Blood. 2009 Apr 2;113(14):3209-17. doi: 10.1182/blood-2008-07-167601. Epub 2008 Dec 19.


Abundance of early functional HIV-specific CD8+ T cells does not predict AIDS-free survival time.

Schellens IM, Borghans JA, Jansen CA, De Cuyper IM, Geskus RB, van Baarle D, Miedema F.

PLoS One. 2008 Jul 23;3(7):e2745. doi: 10.1371/journal.pone.0002745.


IL-7 and the HIV Tat protein act synergistically to down-regulate CD127 expression on CD8 T cells.

Faller E, Kakal J, Kumar R, Macpherson P.

Int Immunol. 2009 Mar;21(3):203-16. doi: 10.1093/intimm/dxn140. Epub 2009 Jan 15.


Continuous improvement in the immune system of HIV-infected children on prolonged antiretroviral therapy.

Weinberg A, Dickover R, Britto P, Hu C, Patterson-Bartlett J, Kraimer J, Gutzman H, Shearer WT, Rathore M, McKinney R; PACTG 1021 team.

AIDS. 2008 Nov 12;22(17):2267-77. doi: 10.1097/QAD.0b013e3283189bb3.


Phenotypic and functional characteristics of HIV-specific CD8 T cells and gag sequence variability after autologous dendritic cells based therapeutic vaccine.

López A, van der Lubbe N, Sánchez-Palomino S, Arnedo M, Nomdedeu M, Castro P, Guilà M, Maleno MJ, García F, Gallart T, Gatell JM, Plana M.

Vaccine. 2009 Oct 19;27(44):6166-78. doi: 10.1016/j.vaccine.2009.08.021. Epub 2009 Aug 26.


Microarray study reveals that HIV-1 induces rapid type-I interferon-dependent p53 mRNA up-regulation in human primary CD4+ T cells.

Imbeault M, Ouellet M, Tremblay MJ.

Retrovirology. 2009 Jan 15;6:5. doi: 10.1186/1742-4690-6-5.


Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses.

Sáez-Cirión A, Sinet M, Shin SY, Urrutia A, Versmisse P, Lacabaratz C, Boufassa F, Avettand-Fènoël V, Rouzioux C, Delfraissy JF, Barré-Sinoussi F, Lambotte O, Venet A, Pancino G; ANRS EP36 HIV Controllers Study Group.

J Immunol. 2009 Jun 15;182(12):7828-37. doi: 10.4049/jimmunol.0803928.


CD4+ and CD8+ T cells expressing FoxP3 in HIV-infected patients are phenotypically distinct and influenced by disease severity and antiretroviral therapy.

Lim A, French MA, Price P.

J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):248-57. doi: 10.1097/QAI.0b013e3181a74fad.


CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals.

Kolber MA.

AIDS. 2008 Oct 1;22(15):1937-41. doi: 10.1097/QAD.0b013e32830f97e2.


Characterization of host genetic expression patterns in HIV-infected individuals with divergent disease progression.

Salgado M, López-Romero P, Callejas S, López M, Labarga P, Dopazo A, Soriano V, Rodés B.

Virology. 2011 Mar 1;411(1):103-12. doi: 10.1016/j.virol.2010.12.037. Epub 2011 Jan 15.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk